Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Medtronic Synchromed Infusion Pump Recall: Drug Overdose Risk February 17, 2011 Staff Writers Add Your Comments A recall has been issued for Medtronic SynchroMed infusion pumps due to design problems, which may lead to refill errors where doctors unknowingly miss the device and inject the drugs directly into the patient. This has resulted in hundreds of reported problems with the Medtronic SynchroMed pump, including at least eight deaths. The FDA classified the Medtronic SynchroMed Infusion Pump recall as a Class I medical device recall this week, meaning that the infusion pump problems carry a reasonable probably of causing serious injury or death. Last month, Medtronic, Inc. sent an “Urgent: Medical Device Correction” letter (pdf) to health care providers warning them that there was a chance that doctors trying to refill pumps implanted in patients could mistakenly inject the drugs directly into the patient’s subcutaneous tissue without knowing it. Known as a “pocket fill,” this could cause serious injury or death due to drug overdose or could cause the patient not to receive the proper amount of medication. MEDTRONIC MINIMED LAWSUITS Did you or a loved one receive a Medtronic MiniMed insulin pump? Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION MEDTRONIC MINIMED LAWSUITS Did you or a loved one receive a Medtronic MiniMed insulin pump? Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to Medtronic’s letter, there have been at least 351 reports of pocket fill problems involving the SynchroMed infusion pump from May 1996 to September 2010. Eight people have died and 270 required medical intervention due to a serious or life threatening injury. Another 58 events are known that did not cause serious injury and there were 15 events where Medtronic did not know the outcome. Medtronic estimates, based on the reports, that about 1 in every 10,000 SynchroMed drug refill attempts by health care professionals result in a pocket fill. However, the company said the actual rate of occurrence could be much higher, because it is likely that the medical mistakes are under reported. The recall affects the SynchroMed II Programmable Pump (model no. 8637), the SynchroMed EL Infusion System (model nos. 8626 and 8627) and Medtronic refill kits (model nos. 8551, 8555, 8561, 8562, 8564, 8565, and 8566). Refill kits for the Medtronic MiniMed Infusion Pumps are not affected. Medtronic’s letter instructs doctors and other healthcare professionals using the affected medical devices to check needle placement within the pump septum during the drug refill. The needle must be inserted until it has reached the needle stop in the pump reservoir. In addition, health care professionals, patients and caregivers should be alert to signs of drug overdose, underdose, and withdrawal after every refill. Any incidents related to the use of the affected pumps should be reported to the FDA’s MedWatch adverse event reporting program at www.fda.gov/MedWatch. Tags: Infusion Pump, Medical Device, Medical Mistake, Medtronic, Overdose More Medtronic MiniMed Lawsuit Stories Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks October 7, 2024 FDA Issues “Do Not Use” Warning for Recalled Medtronic NIM Endotracheal Tubes July 10, 2024 Medfusion Syringe Pump Recall Issued Over Software Errors March 6, 2024 4 Comments Alan May 9, 2016 I’ve had pump for 10+ years, one replacement in 09′ and it just malfunctioned and nearly killed me, I was not aware of the recall until I woke up in hospital being treated for a severe opiate overdose. This was immediately after getting it refilled. Bill I’d like to discuss your incident and anyone else that has been a Medtronic SynchroMed II victim if you could share with me what you did after. Bill April 6, 2015 My wife has a Syncromed II infusion pump. In April 2013, she was given a replacement (her third scheduled one). Each refill with the new pump (from a visiting nurse) always leaked, the 1st time required an ER visit to monitor her (we have video of the leaking). Finally after about 5 leaking refills, her doctor replaced the pump Dec 1st, 2014 and noticed that there was approx 200cc of fluid in the pocket. After the new pump, she started having new problems, finally getting the dosages (or more), that she was supposed to. She then went into withdrawals when the pump ran dry early. I subsequently found out on my own from Google that there was a FDA recall about this is Jan. 2011 but we weren’t notified, nor her doctor, who keeps recall notices from all vendors, but his Medtronic binder is empty. During the withdrawals, she wound up having to be hospitalized, drug-induced coma, respiratory failure, etc. Does she have a case? Roy August 13, 2014 Have had problems with too much medication left in pump at time of refill. Should have been 4.5 and it was 17.5 one month and the next month it was 9.5. Also Having times that I am not getting the pain relief that I would normally expect. What action should I take to resolve this issue? Christine February 22, 2011 Does this mean I have to have my pump replaced? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)